APA (7th ed.) Citation

VH, J., M, A., G, I., S, N., BH, B., G, D., . . . JA, C. (2026). Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort. European urology, 89(2), 108. https://doi.org/10.1016/j.eururo.2025.08.012

Chicago Style (17th ed.) Citation

VH, Jayalath, et al. "Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort." European Urology 89, no. 2 (2026): 108. https://doi.org/10.1016/j.eururo.2025.08.012.

MLA (9th ed.) Citation

VH, Jayalath, et al. "Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort." European Urology, vol. 89, no. 2, 2026, p. 108, https://doi.org/10.1016/j.eururo.2025.08.012.